Profile of patients with gastrointestinal bleeding in reference service during the Sars- Cov-2 pandemic (Covid-19)
DOI:
https://doi.org/10.47456/rbps.v25isupl_2.42345Keywords:
Gastrointestinal hemorrhage, Peptic ulcer, Esophageal and Gastric Varices, Covid-19Abstract
Introduction: Digestive Bleeding (DB)) is an important cause of morbidity, especially the upper gastrointestinalbleeding. During the Sars-CoV-2 pandemic, DB was one of the gastrointestinal symptoms described. Objective: To analyze the profile of patients hospitalized for DB along the 95-day period of pandemic and comparison between infection or not by COVID 19. Methods: Retrospective analysis of medical records of hospitalizations for BD at the University Hospital Cassiano Antonio Moraes. The clinical profile, presentation of the condition, hemodynamic variables, endoscopic findings and Sars-Cov-2 infection were characterized. Results: In the analyzed period, 251 hospitalizations were registered due to BD and in 21 COVID was present. The average age was 60.04 years, one third were male, with an average of 9.2 days in hospital, average hemoglobin of 8.17 mg/dL, duodenal ulcer was the main cause of DB, followed by esophageal varices. Rebleeding occurred in 22 cases and 42 patients died. Conclusion: DB is a clinical complication with high morbidity and high mortality risk. During the period of the COVID 19 pandemic, an increase in mortality was observed among infected patients.
Downloads
References
Savides TJ, Jensen DM. Capitulo 19 Sangramentos Gastroin¬testinais. In:Sleinsenger & Fordtran.Tratado gastrointestinal e doenças do fígado Volume 1. Tradução 9.ed. Rio de Janeiro: Else¬vier; 2014.p.287-327.
American Society for Gastrointestinal Endoscopy. The role of endoscopy in the patient with lower GI bleeding. Gastrointesti¬nal endoscopy, Volume 79, No. 6 : 2014.p.875-885.
Gralnek IM, Dumonceau JM, Kuipers EJ, Lanas A, Sander DS,Kurien M, et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastro¬intestinal Endoscopy (ESGE) Guideline. 2015; 47: a1–a46
Martin TA, Wan DW, Hajifathalian K, Tewani S, Shah SL, Mehta A, et al. Gastrointestinal Bleeding in Patients With Coronavirus Disease 2019: A Matched Case-Control Study. The American Journal of GASTROENTEROLOGY.2020. Volume 00.
Zaltaman C, Souza HSP, Castro MEC, Sobral MF, Dias PC, Lemos Jr V. Upper gastrointestinal bleeding in a brazilian hospi¬tal: a retrospective study of endoscopic records. Arq Gastroen¬terol.2002. V39-no.2,p.74-80.
Aluizio CLS, Montes CG, Reis GFSR, Nagasako CK. Risk strati¬fication in acute variceal bleeding: Far from an ideal score. Clin¬ics. 2021.
Kamboj AK, Hoversten P, L CL. Upper Gastrointestinal Bleed¬ing: Etiologies and Management. Mayo clinic proceedings. 2019.p.697-703.
Weledji EP. Acute upper gastrointestinal bleeding: A review. Surgery in Practice and Science.2020.
Laine L, Jensen DM. Management of Patients With Ulcer Bleeding. The American Journal of GASTROENTEROLOGY. 2012.p.345-360.
Enestvedt BK, Gralnek IM, Mattek N, Liberman DA, Eisen G. An evaluation of endoscopic indications and findings related to nonvariceal upper-GI hemorrhage in a large multicenter consor¬tium. GASTROINTESTINAL ENDOSCOPY Volume 67, No. 3 .2008.p.422-429.
American Society for Gastrointestinal Endoscopy. The role of endoscopy in the management of variceal hemorrhage. Gastro¬intestinal endoscopu. Volume 80, No2: 2014. P.221-227.
Laine L, Barkun NA, Saltzman JR, Mrtel M, Leontiadis GI. ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding. The American Journal of GASTROENTEROLOGY. Volume 116. 2021. P. 899-917.
Stanley AJ, Laine L. Management of acute Upper gastrointesti¬nal bleeding. The BMJ.2019.p.1-13.
Nable JV, Graham A. Gastrointestinal bleeding. Emerg Med Clin N am. 2016.
Mauro A, Grazia F, Lenti MV, Penagini R, Frego R, Ardizzone S, et al. Upper gastrointestinal bleeding in COVID-19 inpatients: Incidence and management in a multicenter experience from Northern Italy. Clinics and Research in Hepatology and Gastro¬enterology 45. 2021.
Marasco G, Maida M, Morreale GC, Licata M, Renzulli M, Cre¬mon C, et al, Gastrointestinal Bleeding in COVID-19 Patients: A Systematic Review with Meta-Analysis. Canadian Journal of Gastroenterology and Hepatology.2021.
Prasoppokakorn T, Kullanvanijaya P, Pittayanon R. Risk fac¬tors of active upper gastrointestinal bleeding in patients with COVID-19 infection and the efectiveness of PPI prophy¬laxis. BMC Gastroenterology.2022.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Brazilian Journal of Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Revista Brasileira de Pesquisa em Saúde (RBPS) adopts the CC BY 4.0 license, which means that authors retain the copyright of the works they submit to the journal. Authors are responsible for declaring that their contribution is an original manuscript, that it has not been previously published, and that it is not under simultaneous review by another scientific journal. Upon submitting the manuscript, authors grant RBPS the exclusive right of first publication, subject to peer review.
Authors are permitted to enter into additional contracts for the non-exclusive distribution of the version published by RBPS (for example, in institutional repositories or as a book chapter), provided that due acknowledgment of authorship and of initial publication by RBPS is given. Authors are also encouraged to make their work available online (for example, in institutional repositories or on their personal pages) after its initial publication in the journal, with due acknowledgment of authorship and of the original publication by RBPS.
Accordingly, under the CC BY 4.0 license, readers have the right to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially;
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
